Clinical Trial Update: Monoclonal Antibody Therapy Plus Cyclosporine and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a monoclonal antibody therapy in combination with cyclosporine and peripheral stem cell transplantation for metastatic breast …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Monoclonal antibody therapy (unspecified)

Snippet

Sponsor: University of California, Davis | Conditions: Breast Cancer | Phase 1 | Status: UNKNOWN